Drugs / Reference0912
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00947661 | Jul 2010 → May 2012 | ocular hypertension, open-angle glaucoma | Sun Pharma Advanced Research Company Limited | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Reference0912 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00947661 ↗ |
| Route | Topical | “Eye drops, once daily, 12 weeks” NCT00947661 ↗ |